Breaking News Instant updates and real-time market news.

ALDR

Alder Biopharmaceuticals

$19.35

0.2 (1.04%)

19:58
08/07/18
08/07
19:58
08/07/18
19:58

Alder Biopharma on track for 2020 launch of eptinezumab, say Piper Jaffray

Piper Jaffray analyst Danielle Brill kept her Overweight rating and $28 price target on Alder Biopharma after its in-line Q2 earnings, saying the company is on track for submission for eptinezumab in Q1 of 2019 with potential launch coming in Q1 of 2020. The analyst states that she still sees the drug as "meaningfully differentiated from the competition due to its rapid onset of action and deep magnitude of efficacy". Brill notes that the stock is compelling given the drug's unique features and large market size, and its latest quarterly update suggests the company can fund its operations into 2020.

  • 07

    Aug

  • 08

    Aug

ALDR Alder Biopharmaceuticals
$19.35

0.2 (1.04%)

08/07/18
STFL
08/07/18
INITIATION
Target $30
STFL
Buy
Alder Biopharmaceuticals initiated with a Buy at Stifel
Stifel analyst Paul Matteis initiated coverage of Alder BioPharmaceuticals with a Buy rating and $30 price target, calling it an attractive, differentiated "pure play" within the migraine antiCGRP prevention market. While Matteis acknowledges it "won't be easy" for Alder to compete with Amgen (AMGN), Novartis (NVS), Eli Lilly (LLY) and Teva (TEVA), he believes the unique profile of eptinezumab remains underappreciated and may allow it to capture meaningful, above consensus share of a large, emerging drug category.
08/06/18
08/06/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Global Blood Therapeutics (GBT) initiated with an Overweight at Piper Jaffray. 2. Welltower (WELL) reinstated with a Neutral at Goldman Sachs. 3. Sage Therapeutics (SAGE) initiated with an Overweight at Piper Jaffray. 4. SoftBank (SFTBY) initiated with a Buy at UBS. 5. Alder Biopharmaceuticals (ALDR) initiated with an Overweight at Piper Jaffray. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/06/18
PIPR
08/06/18
INITIATION
Target $28
PIPR
Overweight
Alder Biopharmaceuticals initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Danielle Brill started Alder Biopharmaceuticals with an Overweight rating and $28 price target. Alder is undervalued despite having a "late-stage, de-risked, and differentiated" asset that addresses the large, under-served migraine population, Brill tells investors in a research note. The analyst finds the stock "very attractive at current levels."
06/27/18
NEED
06/27/18
INITIATION
Target $28
NEED
Buy
Alder Biopharmaceuticals assumed with a Buy at Needham
Needham analyst Serge Belanger assumed Alder Biopharmaceuticals with a Buy rating and a price target of $28, saying the company is positioned as a "rare pure-play migraine story". Belanger cites the positive pivotal phase 3 trial data for its Eptinezumab drug where it met all the endpoints and demonstrated an efficacy profile relative to competitive treatments. The analyst believes that Eptinezumab will appeal to "most severe of migraine patients where it will generate blockbuster-level sales" of over $1B.

TODAY'S FREE FLY STORIES

ROYMY

Royal Mail

$0.00

(0.00%)

05:07
06/17/19
06/17
05:07
06/17/19
05:07
Upgrade
Royal Mail rating change  »

Royal Mail upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOW

Dow Inc.

$51.12

-1.77 (-3.35%)

05:05
06/17/19
06/17
05:05
06/17/19
05:05
Downgrade
Dow Inc. rating change  »

Dow Inc. downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRDBY

Nordea Bank

$0.00

(0.00%)

05:04
06/17/19
06/17
05:04
06/17/19
05:04
Downgrade
Nordea Bank rating change  »

Nordea Bank downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMI

Kinder Morgan

$20.53

(0.00%)

05:03
06/17/19
06/17
05:03
06/17/19
05:03
Downgrade
Kinder Morgan rating change  »

Kinder Morgan downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYMC

Symantec

$19.36

-0.22 (-1.12%)

05:00
06/17/19
06/17
05:00
06/17/19
05:00
Upgrade
Symantec rating change  »

Symantec upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OGE

OGE Energy

$43.42

0.17 (0.39%)

04:56
06/17/19
06/17
04:56
06/17/19
04:56
Initiation
OGE Energy initiated  »

OGE Energy initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:55
06/17/19
06/17
04:55
06/17/19
04:55
General news
Breaking General news story  »

6-Month Bill Auction to…

04:55
06/17/19
06/17
04:55
06/17/19
04:55
Conference/Events
CLSA India economics & strategy luncheon meeting »

India Strategist…

IR

Ingersoll-Rand

$124.65

0.31 (0.25%)

04:55
06/17/19
06/17
04:55
06/17/19
04:55
Conference/Events
Ingersoll-Rand management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

NTGN

Neon Therapeutics

$4.76

-0.15 (-3.06%)

04:55
06/17/19
06/17
04:55
06/17/19
04:55
Conference/Events
Neon Therapeutics management to meet with Mizuho »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 18

    Jun

  • 18

    Jun

NVTA

Invitae

$19.20

-0.43 (-2.19%)

04:55
06/17/19
06/17
04:55
06/17/19
04:55
Conference/Events
Invitae participates in a conference call with JPMorgan »

Life Science Tools &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 06

    Aug

DL

China Distance Education

$5.41

(0.00%)

04:55
06/17/19
06/17
04:55
06/17/19
04:55
Conference/Events
China Distance Education management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 18

    Jun

QRTEA

Qurate Retail

$12.83

-0.4 (-3.02%)

04:55
06/17/19
06/17
04:55
06/17/19
04:55
Conference/Events
Qurate Retail management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 20

    Jun

04:55
06/17/19
06/17
04:55
06/17/19
04:55
General news
Breaking General news story  »

3-Month Bill Auction to…

GNL

Global Net Lease

$19.58

0.13 (0.67%)

04:55
06/17/19
06/17
04:55
06/17/19
04:55
Conference/Events
Global Net Lease management to meet with B. Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

ITT

ITT

$62.33

-0.54 (-0.86%)

04:55
06/17/19
06/17
04:55
06/17/19
04:55
Conference/Events
ITT management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

TGODF

The Green Organic Dutchman

$0.00

(0.00%)

04:55
06/17/19
06/17
04:55
06/17/19
04:55
Conference/Events
The Green Organic Dutchman Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 18

    Jun

04:55
06/17/19
06/17
04:55
06/17/19
04:55
Conference/Events
Stephens banking analysts to hold an analyst/industry conference call »

Analysts, along with the…

AGTC

Applied Genetic

$3.89

0.04 (1.04%)

04:55
06/17/19
06/17
04:55
06/17/19
04:55
Conference/Events
Applied Genetic management to meet with Wedbush »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 18

    Jun

AMRS

Amyris

$3.93

-0.16 (-3.91%)

04:55
06/17/19
06/17
04:55
06/17/19
04:55
Conference/Events
Amyris management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 18

    Jun

IONS

Ionis Pharmaceuticals

$62.07

-1.79 (-2.80%)

04:55
06/17/19
06/17
04:55
06/17/19
04:55
Conference/Events
Ionis Pharmaceuticals management to meet with Piper Jaffray »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 18

    Jun

RTIX

RTI Surgical

$4.20

-0.09 (-2.10%)

04:55
06/17/19
06/17
04:55
06/17/19
04:55
Conference/Events
RTI Surgical management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

DEI

Douglas Emmett

$41.26

-0.24 (-0.58%)

04:55
06/17/19
06/17
04:55
06/17/19
04:55
Conference/Events
Douglas Emmett management to meet with KeyBanc »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 18

    Jun

LH

LabCorp

$166.42

-1.525 (-0.91%)

04:55
06/17/19
06/17
04:55
06/17/19
04:55
Conference/Events
LabCorp management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

04:55
06/17/19
06/17
04:55
06/17/19
04:55
General news
Empire State Mfg Survey General Business Conditions Index to be reported at 08:30 »

June Empire State Mfg…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.